Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedJun 02, 2025
DataAggregated Company Financials
Companies11
  • 7D-0.3%
  • 3M17.5%
  • 1Y4.2%
  • YTD2.3%

Over the last 7 days, the Life Sciences industry has remained flat, although notably Promimic gained 11%. The past year has been better, since the industry has gained 4.2% in that time. Earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 02 Jun 2025SEK 45.8bSEK 16.6bSEK 404.2m72.2x113.2x2.8x
Wed, 30 Apr 2025SEK 44.3bSEK 16.6bSEK 642.3m44.2x69x2.7x
Fri, 28 Mar 2025SEK 36.3bSEK 16.6bSEK 609.4m38.1x59.5x2.2x
Sun, 23 Feb 2025SEK 41.8bSEK 16.6bSEK 615.4m41.4x67.9x2.5x
Tue, 21 Jan 2025SEK 38.5bSEK 16.7b-SEK 1,152,911,426.0042.4x-33.4x2.3x
Thu, 19 Dec 2024SEK 43.6bSEK 16.7b-SEK 1,152,911,426.0049.5x-37.9x2.6x
Sat, 16 Nov 2024SEK 43.1bSEK 16.8b-SEK 948,072,426.0047x-45.5x2.6x
Mon, 14 Oct 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.4x-47.7x2.8x
Wed, 11 Sep 2024SEK 49.4bSEK 16.7b-SEK 988,176,492.0060.9x-50x3x
Fri, 09 Aug 2024SEK 47.4bSEK 16.7b-SEK 1,128,120,510.0059.8x-42x2.8x
Sun, 07 Jul 2024SEK 43.8bSEK 16.3b-SEK 1,188,686,510.0057x-36.8x2.7x
Tue, 04 Jun 2024SEK 43.3bSEK 16.3b-SEK 1,188,686,510.0063x-36.5x2.7x
Thu, 02 May 2024SEK 38.5bSEK 16.2b-SEK 1,241,845,705.0037.4x-31x2.4x
Sat, 30 Mar 2024SEK 40.6bSEK 16.0b-SEK 1,122,792,210.0035.6x-36.2x2.5x
Mon, 26 Feb 2024SEK 38.7bSEK 15.9b-SEK 1,122,859,158.0042.6x-34.5x2.4x
Wed, 24 Jan 2024SEK 37.1bSEK 15.5b-SEK 1,393,723,683.0045.2x-26.6x2.4x
Fri, 22 Dec 2023SEK 36.9bSEK 15.5b-SEK 1,393,723,683.0043.4x-26.5x2.4x
Sun, 19 Nov 2023SEK 33.1bSEK 15.4b-SEK 1,398,076,683.0035.5x-23.6x2.1x
Tue, 17 Oct 2023SEK 23.8bSEK 15.1b-SEK 1,134,516,711.0033.1x-21x1.6x
Thu, 14 Sep 2023SEK 27.8bSEK 15.1b-SEK 1,133,713,072.0038.8x-24.5x1.8x
Sat, 12 Aug 2023SEK 31.7bSEK 15.1b-SEK 213,871,038.0046.2x-148.2x2.1x
Mon, 10 Jul 2023SEK 36.2bSEK 14.6b-SEK 172,476,038.0039x-209.8x2.5x
Wed, 07 Jun 2023SEK 39.8bSEK 14.6b-SEK 172,476,038.0039.9x-230.9x2.7x
Fri, 05 May 2023SEK 39.1bSEK 14.6b-SEK 131,406,792.0036.1x-297.6x2.7x
Sun, 02 Apr 2023SEK 33.1bSEK 14.6b-SEK 57,185,459.0032.5x-578.2x2.3x
Tue, 28 Feb 2023SEK 37.4bSEK 14.6b-SEK 59,119,459.0030.6x-633x2.6x
Thu, 26 Jan 2023SEK 38.8bSEK 14.2bSEK 943.9m38.5x41.1x2.7x
Sat, 24 Dec 2022SEK 38.7bSEK 14.1bSEK 944.3m40.6x40.9x2.7x
Mon, 21 Nov 2022SEK 37.5bSEK 14.1bSEK 944.1m40.9x39.7x2.6x
Wed, 19 Oct 2022SEK 35.3bSEK 13.5bSEK 750.9m53.3x47x2.6x
Fri, 16 Sep 2022SEK 36.7bSEK 13.5bSEK 750.9m52.9x48.8x2.7x
Sun, 14 Aug 2022SEK 46.2bSEK 13.2bSEK 667.4m48x69.3x3.5x
Tue, 12 Jul 2022SEK 47.5bSEK 13.2bSEK 753.4m41.6x63x3.6x
Thu, 09 Jun 2022SEK 54.6bSEK 13.2bSEK 753.4m47.7x72.4x4.1x
Price to Earnings Ratio

72.4x


Total Market Cap: SEK 54.6bTotal Earnings: SEK 753.4mTotal Revenue: SEK 13.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -54.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 113x which is higher than its 3-year average PE of -54.3x.
  • The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 19% per year over the last three years.
  • Meanwhile revenues for these companies have grown 7.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.41%
Healthcare0.79%
Life Sciences-0.34%
Clinical Research and Equipment-0.34%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRO PromimicSEK 18.9510.8%
+SEK 35.0m
-40.8%PS7.2x
MAGLE Magle Chemoswed HoldingSEK 27.403.8%
+SEK 20.5m
-18.9%PE72.2x
BIOT BiotageSEK 141.800.07%
+SEK 8.4m
-23.7%PE44.5x
IDLDX IDL DiagnosticsSEK 0.595.4%
+SEK 6.9m
33.8%PS2.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GENO

SEK 26.05

Genovis AB (publ.)

7D

-1.3%

1Y

-30.7%

BIOT

SEK 141.80

Biotage

7D

0.07%

1Y

-23.7%

MAGLE

SEK 27.40

Magle Chemoswed Holding

7D

3.8%

1Y

-18.9%

PRO

SEK 18.95

Promimic

7D

10.8%

1Y

-40.8%

MCAP

SEK 435.50

MedCap

7D

-2.2%

1Y

-18.3%

IDLDX

SEK 0.59

IDL Diagnostics

7D

5.4%

1Y

33.8%

ALIF B

SEK 184.40

AddLife

7D

-0.05%

1Y

62.5%

BICO

SEK 35.94

BICO Group

7D

-1.4%

1Y

-19.3%

PEXA B

SEK 0.31

PExA

7D

-3.1%

1Y

-34.2%

LEVBIO

SEK 0.39

Level Bio

7D

-13.3%

1Y

-7.1%